← Back to Clinical Trials
Recruiting NCT07236008

NCT07236008 Training and Testing Database for IMU Based Gait Analysis Methods

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07236008
Status Recruiting
Phase —
Sponsor Vrije Universiteit Brussel
Condition Healthy Subjects or Volunteers
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2025-12-12
Primary Completion 2029-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2025-12-12 with a primary completion date of 2029-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to establish a high-quality, synchronised dataset of gait events (GE) by simultaneously collecting inertial measurement unit (IMU) data and validated ground truth detections using a Vicon motion capture system. The primary objective is to address existing limitations in GE detection - such as poor generalisability, limited data diversity, and lack of precise synchronisation - through a rigorous protocol that ensures accuracy and transparency. The experiment is structured in three phases. First, Vicon-derived GE will be validated and refined using complementary modalities (force plates and video recordings). Next, deep learning (DL) algorithms will be developed and evaluated for GE detection directly from IMU data, with Vicon annotations serving as ground truth. Finally, the impact of differences in GE timing on spatiotemporal gait parameters (SGP) will be analysed to assess the feasibility of using IMU-only systems for reliable gait analysis. By achieving these objectives, the study aims to improve the accuracy of GE detection from wearable sensors and enable more accessible, scalable, and reliable gait analysis outside the laboratory environment.

Eligibility Criteria

Inclusion Criteria: * Healthy subjects with no motor impairments that disrupt the walking pattern. * No history of pain in the lower limbs in the past 6 months. * No history of lower limbs injuries/surgeries in the past 6 months. * Language: Dutch and/or English and/or French speakers. * Age 18-65 years old * Subjects must be able to understand the instructions and to answer questions. Additionally, they should be able to; signal pain, fear, discomfort; give inform consent. Exclusion Criteria: * Persons with comorbidity that could hinder the study (e.g.: unstable cardiovascular system disorders, lung disorders, severe osteoporosis). * Individuals with metal implants or skin conditions that would make sensor or marker placement difficult.

Contact & Investigator

Central Contact

Redona Brahimetaj, Doctor of Engineering Sciences

✉ redona.brahimetaj@vub.be

📞 0032465597448

Frequently Asked Questions

Who can join the NCT07236008 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Healthy Subjects or Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07236008 currently recruiting?

Yes, NCT07236008 is actively recruiting participants. Contact the research team at redona.brahimetaj@vub.be for enrollment information.

Where is the NCT07236008 trial being conducted?

This trial is being conducted at Brussels, Belgium.

Who is sponsoring the NCT07236008 clinical trial?

NCT07236008 is sponsored by Vrije Universiteit Brussel. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology